|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2003-9-18
|
|
pubmed:abstractText |
Many patients with the antiphospholipid antibody syndrome and recurrent thrombosis receive doses of warfarin adjusted to achieve an international normalized ratio (INR) of more than 3.0. However, there are no prospective data to support this approach to thromboprophylaxis.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:AndersonDavidD,
pubmed-author:ClarkeAnnA,
pubmed-author:CostantiniLorrieL,
pubmed-author:CrowtherMark AMA,
pubmed-author:DenburgJudahJ,
pubmed-author:DouketisJamesJ,
pubmed-author:ForgieMelissaM,
pubmed-author:FortinPaulP,
pubmed-author:GeertsWilliamW,
pubmed-author:GentMichaelM,
pubmed-author:GinsbergJeff SJS,
pubmed-author:GreenDavidD,
pubmed-author:HirshJackJ,
pubmed-author:JulianJimJ,
pubmed-author:KearonCliveC,
pubmed-author:KovacsMichael JMJ,
pubmed-author:LaskinCarlC,
pubmed-author:WilsonSarahS,
pubmed-author:YacuraWendyW
|
|
pubmed:copyrightInfo |
Copyright 2003 Massachusetts Medical Society
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
18
|
|
pubmed:volume |
349
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1133-8
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:13679527-Adult,
pubmed-meshheading:13679527-Aged,
pubmed-meshheading:13679527-Aged, 80 and over,
pubmed-meshheading:13679527-Antibodies, Antiphospholipid,
pubmed-meshheading:13679527-Anticoagulants,
pubmed-meshheading:13679527-Antiphospholipid Syndrome,
pubmed-meshheading:13679527-Double-Blind Method,
pubmed-meshheading:13679527-Female,
pubmed-meshheading:13679527-Follow-Up Studies,
pubmed-meshheading:13679527-Hemorrhage,
pubmed-meshheading:13679527-Humans,
pubmed-meshheading:13679527-International Normalized Ratio,
pubmed-meshheading:13679527-Male,
pubmed-meshheading:13679527-Middle Aged,
pubmed-meshheading:13679527-Myocardial Infarction,
pubmed-meshheading:13679527-Pulmonary Embolism,
pubmed-meshheading:13679527-Recurrence,
pubmed-meshheading:13679527-Stroke,
pubmed-meshheading:13679527-Venous Thrombosis,
pubmed-meshheading:13679527-Warfarin
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.
|
|
pubmed:affiliation |
Department of Medicine, McMaster University, Hamilton, Ont, Canada. crowthrm@mcmaster.ca
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
